Topic Hub
9 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 9 of 9 clinical reviews.
A clinical evidence summary of off-label finasteride use in female pattern hair loss (FPHL), including trial data, dosing protocols, safety considerations, and guideline positions.
Read clinical reviewAn evidence-based review of off-label finasteride use in female pattern hair loss, covering trial data, dosing, teratogenicity risk, and who may benefit.
Read clinical reviewA clinical deep-dive into off-label finasteride for female pattern hair loss (FPHL): evidence level, dosing protocols, contraindications, and how it compares to approved alternatives.
Read clinical reviewFinasteride is FDA-approved for male androgenetic alopecia but used off-label in female pattern hair loss. Learn the evidence, dosing, monitoring requirements, and safety considerations for women.
Read clinical reviewA clinical review of finasteride's off-label use in gender-affirming hormone therapy, including evidence quality, dosing protocols, and safety considerations for transgender patients.
Read clinical reviewA detailed clinical review of off-label finasteride use in gender-affirming care for transgender women and nonbinary people, covering evidence quality, dosing, side effects, and how it compares to other antiandrogens.
Read clinical reviewFinasteride is used off-label for hirsutism in women at 2.5 to 5 mg/day. Learn the dosing protocol, trial evidence, contraindications, and how it compares to spironolactone.
Read clinical reviewA clinical evidence summary of off-label finasteride use for hirsutism, including trial data, dosing protocols, safety concerns, and how it compares to spironolactone and flutamide.
Read clinical reviewFinasteride is used off-label for hirsutism in women. Review the clinical trial data, side-effect profile, pregnancy contraindication, dosing, and how it compares to spironolactone.
Read clinical review